|Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association|
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
Circulation 129 (3), 399-410, 2014
|From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I|
M Naghavi, P Libby, E Falk, SW Casscells, S Litovsky, J Rumberger, ...
Circulation 108 (14), 1664-1672, 2003
|Biological, clinical and population relevance of 95 loci for blood lipids|
TM Teslovich, K Musunuru, AV Smith, AC Edmondson, IM Stylianou, ...
Nature 466 (7307), 707-713, 2010
|Antiinflammatory therapy with canakinumab for atherosclerotic disease|
PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ...
New England journal of medicine 377 (12), 1119-1131, 2017
|Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial|
SE Nissen, SJ Nicholls, I Sipahi, P Libby, JS Raichlen, CM Ballantyne, ...
Jama 295 (13), 1556-1565, 2006
|American heart association statistics committee and stroke statistics subcommittee|
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
Heart disease and stroke statistics-2017 update: a report from the American …, 2017
|Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)|
PH Jones, MH Davidson, EA Stein, HE Bays, JM McKenney, E Miller, ...
The American journal of cardiology 92 (2), 152-160, 2003
|Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities …|
SJ Hwang, CM Ballantyne, AR Sharrett, LC Smith, CE Davis, AM Gotto Jr, ...
Circulation 96 (12), 4219-4225, 1997
|Effects of dalcetrapib in patients with a recent acute coronary syndrome|
GG Schwartz, AG Olsson, M Abt, CM Ballantyne, PJ Barter, J Brumm, ...
New England Journal of Medicine 367 (22), 2089-2099, 2012
|Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association|
M Miller, NJ Stone, C Ballantyne, V Bittner, MH Criqui, HN Ginsberg, ...
Circulation 123 (20), 2292-2333, 2011
|The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study|
AM McNeill, WD Rosamond, CJ Girman, SH Golden, MI Schmidt, HE East, ...
Diabetes care 28 (2), 385-390, 2005
|Efficacy and safety of evolocumab in reducing lipids and cardiovascular events|
MS Sabatine, RP Giugliano, SD Wiviott, FJ Raal, DJ Blom, J Robinson, ...
New England Journal of Medicine 372 (16), 1500-1509, 2015
|Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein (a), apolipoproteins AI and B, and HDL density subfractions: The …|
AR Sharrett, CM Ballantyne, SA Coady, G Heiss, PD Sorlie, D Catellier, ...
Circulation 104 (10), 1108-1113, 2001
|Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study|
BB Duncan, MI Schmidt, JS Pankow, CM Ballantyne, D Couper, A Vigo, ...
Diabetes 52 (7), 1799-1805, 2003
|Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association|
MA Hlatky, P Greenland, DK Arnett, CM Ballantyne, MH Criqui, ...
Circulation 119 (17), 2408-2416, 2009
|Comprehensive overview of nursing and interdisciplinary rehabilitation care of the stroke patient: a scientific statement from the American Heart Association|
EL Miller, L Murray, L Richards, RD Zorowitz, T Bakas, P Clark, ...
Stroke 41 (10), 2402-2448, 2010
|Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study|
V Nambi, L Chambless, AR Folsom, M He, Y Hu, T Mosley, K Volcik, ...
Journal of the American College of Cardiology 55 (15), 1600-1607, 2010
|T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity|
H Wu, S Ghosh, XD Perrard, L Feng, GE Garcia, JL Perrard, JF Sweeney, ...
Circulation 115 (8), 1029, 2007
|Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in …|
CM Ballantyne, RC Hoogeveen, H Bang, J Coresh, AR Folsom, G Heiss, ...
Circulation 109 (7), 837-842, 2004
|Effect of two intensive statin regimens on progression of coronary disease|
SJ Nicholls, CM Ballantyne, PJ Barter, MJ Chapman, RM Erbel, P Libby, ...
New England Journal of Medicine 365 (22), 2078-2087, 2011